Amesite Inc. SEC 10-Q Report

Amesite Inc. has released its Q3 2025 Form 10-Q report, showing improved financial performance with net revenue rising to $0.094 million from $0.011 million. The company reported a reduced loss from operations of $(0.662) million and a net loss of $(0.642) million. A strategic pivot towards the healthcare sector is evident, with 26% of revenue now from individual customers. The launch of the NurseMagic™ app marks this shift. Cost management strategies have been implemented, and future cash generation plans include potential stock offerings, subject to market conditions.

Amesite Inc., a leading provider of artificial intelligence software products, has released its Form 10-Q report for the third quarter of 2025. The report highlights significant improvements in financial performance and a strategic pivot towards the healthcare industry, reflecting the company's adaptive approach to market demands and operational efficiency.

Financial Highlights

Net Revenue: $0.094 million, increased from $0.011 million in the prior year period, reflecting a focus on growing the customer base.
Loss from Operations: $(0.662) million, improved from $(0.927) million in the prior year period, due to reductions in operating expenses.
Net Loss: $(0.642) million, improved from $(0.908) million in the prior year period, driven by cost reductions and increased revenue.
Basic and diluted loss per share: $(0.14), improved from $(0.34) in the prior year period, reflecting a decrease in net loss.

Business Highlights

Revenue Segments: For the three months ended September 30, 2025, Amesite Inc. generated 26% of its revenue from individual customers (B2C) and 74% from business customers (B2B). This marks a significant shift from the same period in 2024, where 100% of revenue was derived from business customers.
New Product Launches: Amesite Inc. has introduced the NurseMagic™ app, a mobile healthcare application designed to streamline nursing documentation, enhance patient communication, and provide personalized guidance to nurses. This launch represents a strategic pivot towards the healthcare industry.
Operational Strategy Shift: The company has shifted its focus from securing academic customers to offering solutions for the healthcare industry, driven by the belief that AI-powered programs will eventually replace traditional academic products. This strategic change aims to tap into markets with immediate demand for enhanced capabilities.
Cost Management: Amesite Inc. has reduced general and administrative expenses by lowering payroll costs and professional fees, attributed to the completion of certain platform features that require less staffing to maintain.
Technology and Content Development: The company has decreased its technology and content development expenses by reducing headcount and associated administrative costs, reflecting a more efficient operational structure.
Sales and Marketing Adjustments: There has been a reduction in sales and marketing expenses due to the transition of certain marketing functions from external providers to internal staff, optimizing cost efficiency.
Future Outlook: Management plans to generate cash through financing transactions, including potential offerings of common stock, to address the company's ongoing cash needs. However, these plans are subject to market conditions and are not guaranteed.

SEC Filing: Amesite Inc. [ AMST ] - 10-Q - Oct. 24, 2025